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A B  S  TRA C  T  The effects of NO-related activity and cellular thiol redox state on basal L-type calcium current, ICa,L , 
in ferret right ventricular myocytes were studied using the patch clamp technique.  SIN-I, which generates both 
NO- and O2-, either inhibited or stimulated ICa,L. In the presence of superoxide dismutase only inhibition was 
seen. 8-Br-cGMP also inhibited  ICa,L, suggesting that the NO inhibition is cGMP-dependent. On the other hand, 
S-nitrosothiols (RSNOs), which donate NO +, stimulated ICa,L. RSNO effects were not dependent upon cell perme- 
ability, modulation of SR Ca  2+ release, activation of kinases, inhibition  of phosphatases, or alterations in cGMP 
levels. Similar activation of Ica,L by thiol oxidants, and reversal by thiol reductants, identifies an allosteric thiol-con- 
raining "redox switch" on the L-type calcium channel subunit complex by which NO./O  2- and NO + transfer can 
exert effects opposite to those produced by NO.. In sum, our results suggest that: (a) both indirect (cGMP-depen- 
dent)  and direct (S-nitrosylation/oxidation)  regulation of ventricular I<:a,t., and (b)  sarcolemma thiol redox state 
may be an important determinant of ICa,L activity. 
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INTRODUCTION 
Nitric  oxide  (NO-related  activity)  plays  a  key role  in 
many important biological responses, including vasodi- 
lation,  platelet inhibition,  immune  responses,  cell  ad- 
hesion,  and  neurotransmission  (Ignarro,  1990;  Mar- 
Ietta et al.,  1990;  Moncada  et al.,  1991;  Stamler et al., 
1992b;  Snyder,  1992;  Schmidt et al.,  1993;  Michel  and 
Smith,  1993;  Dinerman  et  al.,  1993;  Shah  and  Lewis, 
1993;  Lincoln,  1994;  Schmidt and Walter,  1994;  Stam- 
ler,  1995;  Feelisch  and  Stamler,  1996).  It is  believed 
that  the  free  radical  NO.  exerts  many  of its  effects 
through  an  indirect  pathway  involving  activation  of 
guanylate  cyclase  and  increased  levels  of  cyclic  gua- 
nosine  monophosphate  (cGMP).  However, NO  signal- 
ling also encompasses the actions of other naturally oc- 
curring N-oxides, such as S-nitrosothiols  (RSNOs) 1 and 
peroxynitrite  (OONO-)  which  display  reactivity  pro- 
Preliminary accounts of this work have appeared previously in abstract 
form  (Campbell et al.  1995.  Circulation.  92:I-433; Campbell et al.  1995. 
Endothelium.  3[Suppl.]:S36; Campbell et al. 1996. Biophys.J.  70:A314). 
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files that are different from NO.  itself (Stamler et al., 
1992b). In particular, the NO group of RSNOs has NO + 
properties that enable S-nitrosylation of proteins, while 
peroxynitrite  oxidizes  protein  thiols  (Freelisch  and 
Stamler,  1996).  As a  result, cellular redox state can be 
an  important  factor  in  determining  NO-related  re- 
sponses (Stamler et al., 1992b). 
Posttranslational  modification  of protein  thiols  can 
regulate  protein  function.  Regulation  by  redox  state 
and NO/RSNOs has been described for numerous in- 
tra-  and  extracellular  proteins  (e.g.,  Stamler  et  al. 
1992a,  b;  Gopalakrishna  et  al.,  1993;  Lander  et  al., 
1993;  Duhe  et  al.,  1994;  Stamler,  1994,  1995).  Mem- 
brane bound ion channels have received particular at- 
tention  (e.g.,  Ruppersberg  et  al.,  1991;  Lipton  et  al., 
1993;  Bolotina et al.,  1994;  Stamler,  1994;  Gozlan and 
Ben-Ari,  1995;  Stamler,  1995;  Lipton et al.,  1996).  Di- 
rect effects of N-oxides appear to derive from reactions 
of vicinal thiols that serve as allosteric regulators of pro- 
tein and channel function  (Lipton et al., 1993; Stamler, 
1994; Stamler,  1995).  In addition  to direct redox regu- 
lation,  NO can modify ion channel function  by cGMP 
(e.g., Schmidt et al.,  1993; Lincoln,  1994). Thus, a pic- 
ture  has  emerged  wherein  NO-regulation  of cellular 
functions  occurs via either  cGMP  or  S-nitrosylation/ 
oxidation  of metal- and/or  thiol-containing  proteins. 
Nonetheless, it is still widely believed that different NO- 
related species exert similar or identical effects on cellu- 
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nalling mechanisms. Furthermore, dual mechanisms of 
ion channel modulation have not been described for NO. 
In cardiac muscle, the  L-type calcium current,  IC,,L, 
triggers  the  excitation-contraction  coupling  process 
through Ca')+-induced Ca  `)+ release from the sarcoplas- 
mic reticulum (Bers, 1991; Wier, 1992). Mechanisms of 
indirect  modulation  of  Ic,  a.  by  intr.acellular second 
messenger pathways have attracted intense experimen- 
tal  attention  (Hartzell,  1988;  McDonald  et  al.,  1994; 
Campbell and Strauss,  1995). With regard  to NO  and 
cardiac  function, it  has  been  demonstrated  that:  (a) 
NO-related activity can  modulate cardiac  contractility 
both in vivo and in vitro  (Brady et al.,  1993; Shah and 
Lewis,  1993;  Balligand et  al.,  1995;  Hare  et al.,  1995; 
Mohan et al., 1996);  (b) NO may be indirectly involved 
in muscarinic inhibition of [3-adrenergically stimulated 
Ic,.L  either  through  activation  of  cGMP-dependent 
phosphodiesterases  (Fischmeister  and  Shrier,  1989; 
Mery  et  al.,  1993;  Han  et  al.,  1994,  1995)  or  cGMP- 
dependent protein kinase and/or  phosphatases  (Levi 
et  al.,  1989;  Mery  et  al.,  1991;  Mubagwa et  al.,  1993; 
Herzig et al.,  1993; Levi et al.,  1994; Summii and Spe- 
relakis,  1995; Wahler and Dollinger, 1995); and  (c)  at 
least some working cardiac myocyte types possess a con- 
stitutive nitric oxide  synthase  (NOS;  Balligand et  al., 
1995; Kanai et al., 1995)  and a  Ca`)+-independent NOS 
(iNOS) which can be upregulated upon exposure to cy- 
tokines (Brady et al., 1992; Finkel et al., 1992; Balligand 
et al.,  1994; Haywood et al.,  1996).  However, in all of 
these  previous  studies  the  molecular  identity  of  the 
NO-related effector species was assumed to be equiva- 
lent  to  free  radical  NO.,  and  neither  cellular  redox 
state or possible direct effects were considered. 
In this paper we  demonstrate for the first time that 
NO-related modulation of the sarcolemmal L-type cal- 
cium  channel  of  mammalian cardiac  muscle  can  in- 
volve both indirect control by cGMP and direct control 
by channel subunit S-nitrosylation/oxidation. We also 
demonstrate that these two signalling pathways have op- 
posite effects upon L-type calcium channel function. Fi- 
nally, we demonstrate that sarcolemmal thiol redox state 
can directly and selectively modulate ventricular It:~,L. 
METHODS 
Myocyte Isolation, Electrophysiological Techniques,  and 
Data Analysis 
Single myocytes were  enzymatically  isolated  (collagenase, pro- 
tease, elastase) from the right ventricles of 10-20 wk-old male fer- 
rets  via  the  Langendorff perfusion  method  as  previously  de- 
scribed (Campbell et al.,  1993; Qu et al.,  1993a, b). Alter isola- 
tion, myocytes were  stored in normal (1.8 mM CaCI> 5.4  mM 
KC1) control saline (described below) at room temperature (22- 
24~  until used. All experiments were conducted within 6-12 h 
after initial myocyte isolation. 
Myocytes were  voltage  clamped  using the  single-microelec- 
trode "gigaseal" patch clamp technique in the whole cell record- 
ing configuration (Hamill et al., 1981; Marry and Neher,  1995). 
The amplifier was an Axopatch 1-C (Axon Instruments, Inc., Fos- 
ter City, CA). All other recording and stimulating apparatus, as 
well as recording chamber, simple gravity feed perfnsion system, 
inverted microscope, and modified stage, were as previously de- 
scribed in detail (Campbell et aI., 1993; Qu et al., 1993a, b). Patch 
pipettes were  fabricated from  1.5-mm O.D.  borosilicate tubing 
(TW 150F-4; WP Instruments) and gently heat polished to a final 
approximate diameter of 1 Ixm (MF-83 microforge; Narishige Sci- 
entific Instruments, Tokyo,Japan). When filled with intracellular 
recording solution (described below) pipette resistances were 2-5 
MI). After zeroing current flow across the pipette tip (junction 
potentials were 5 mV or less and have not been corrected for in 
the  data presented), gigaseals  were  initially fbrmed in normal 
Na  + solution (described below).  After  obtaining the whole  cell 
configuration, at least 10 rain were allowed to pass to allow ade- 
quate internal perfusion and stabilization of current gating pa- 
rameters (Marry and Neher, 1995). 
Current traces and voltage clamp pulses were recorded on vid- 
eotape using a 4-channel A/D VCR adaptor (PCM 4; Medical Sys- 
tems  Corp.,  Greenvale,  NY). Currents  were  filtered  (8  pole 
Bessel) at 1-2 kHz and were subsequently digitized offiine using 
a 125 kHz A/D board under pCLAMP software control (Axon In- 
struments). MI analysis was conducted on Ic:~.t. recordings that 
were  not "leakage  corrected" using commercially available soft- 
ware  packages  (pCLAMP, Lotus,  FigP).  Measurements of both 
the mean peak and isochronal 500 ms I-V relationship or extrap- 
olation of "leak currents" from linear regression of data obtained 
from -70 to -40 mV (no net inward current activated; see Fig. 4 
A) indicated that the mean peak leak current under both control 
and S-nitrosoglutathione conditions was only 1-2.4% of the mean 
peak I<,.~.  at 0 mV. Therefore, the residual nonsubtracted leakage 
current was not a significant contributing factor in the results 
presented. When applicable, statistical significance was tested ns- 
ing a paired t test at P< 0.05. Data are presented as mean _+SEM. 
M1 reported measurements were on the basal lc~.~., i.e., I<,j. re- 
corded without any previous [3-adrenergic stimulation or musca- 
rinic inhibition. All experiments were  conducted at room tem- 
perature (22-24~  In all experiments myocytes were held at a 
holding potential of liP =  -70 inV. The data points in all figures 
correspond to the net peak inward Ic,~.L elicited in response to a 
500 ms voltage  clamp pulse to 0 mV applied at a frequency of 
0.167 Hz, except for the results presented in Fig. 4 (I-V curve, in- 
activation kinetics). Due to the slow and variable (~1-2 ml/min) 
pmTusion  times  of the  recording chamber  used  (vol ~2  ml; 
Campbell et al., 1993; Qu et al., 1993a, b), no quantitative conclu- 
sions  on  the  kinetics  of  onset  of  compound  effects  can  be 
reached  from  the  data  presented; hence,  effects  are  given as 
mean values  after  steady-state  conditions had  been  obtained. 
These factors, in combination with possible differences in redox 
state of individual myocytes, account for the variable time-course 
of effects illustrated in some of the figures.  In an attempt to ac- 
count for celhdar variability', possible differences in internal per- 
fl~sion, and other experimental variables,  mean reults from at 
least n -> 3 myocytes were obtained for each specific experimen- 
tal manipulation. 
Solutions and Compounds 
Previous  studies from our laboratory (Qu et al.,  1993a, b)  have 
demonstrated that ferret right ventricular myocytes do not ap- 
pear to possess a macroscopically  measurable T-type calcium cur- 
rent.  Hence,  the  calcium currents analyzed  in  this  study are 
purely L-type. Gigaseals were formed and the whole cell configu- 
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NaCI, 5.4 KC1, 1 MgSO4, 1.8 CaCI> 10 HEPES, pH  =  7.40.  Myo- 
cytes were then subsequently perfused with an Na +- and K+-free 
extracellular  Ic,,r,  solution  (mM):  144  ALmethyl-D-glucamine-Cl 
(NMDG-C1), 5.4 CsC1, 1 MgSO4, 1.8 CaCI> 10 HEPES, pH =  7.40. 
The patch pipette contained K+-free intracellular solution (mM): 
120 CsCI, 20 TEA-CI, 1 MgSO4, 5 EGTA, 5 Mg-ATP, 5 Tris creat- 
ine phosphate, 0.2 GTP, 10 HEPES, pH =  7.40. As has been pre- 
viously demonstrated  (Qu et al.,  1993a,  b),  by using these solu- 
tions a pure Ica,i, can be recorded from these myocytes over peri- 
ods of up to 45-60 min without any significant "run down" (e.g., 
Figs. 5, 6 B, and 9 A and D). Whether this represents appropriate 
properties of the recording solutions used or instead is a  reflec- 
tion of different intracellular regulatory properties that minimize 
run  down  of ferret right ventricular basal  Ica,[ ' is presently un- 
clear. In any event, in nearly all circumstances an experiment was 
terminated due to factors other than run down  (typically loss of 
seal  resistance).  As a  result,  the  "perforated  patch"  technique 
(e.g., Horn and Marry, 1988; Han et al., 1994,  1995)  was not used. 
Stock solutions (50 mM) of S-nitrosothiols were freshly synthe- 
sized by mixing equal volumes of 100  mM reduced glutathione 
or L-cysteine in 250 mM HC1, 0.1 mM EDTA and 100 mM NaNO  2 
in  distilled  water  at  room  temperature  (Arnelle  and  Stamler, 
1995)  and stored in the dark on ice until  used.  Stocks were di- 
luted  (with readjustment of pH back to 7.40 with CsOH)  in the 
extracellular Ic~.l. recording solution to a final concentration of 1 
mM  immediately  before  use.  Staurosporine  was  dissolved  in 
DMSO to give stock solutions that were refrigerated until  used. 
These stocks were then diluted in extracellular I(:~,,t solution to a 
final  staurosporine  concentration  of 200  nM.  While  the  final 
level of DMSO in the IC~.L solution  (--< 0.1%)  had no measurable 
effect  upon  I{:~.~., in  experiments  involving  staurosporine  an 
equal amount of DMSO was added to the control Ic,.l solution to 
serve as an internal control for possible solvent effects. Aliquots 
of stock solutions of H-7 (1-[5-isoquinolinesulfonyl]-2-methylpip- 
erazine-HC1) were made in extracellular Ica,L solution, stored in 
the  refrigerator,  and  diluted  immediately before  use  to a  final 
concentration of 50 pM. SIN-1  (3-morpholinosydnoninfine-HC1) 
solutions were  made  fresh  for each  individual experiment and 
were used within 5-10 min of preparation.  Reduced glutathione, 
cysteine, superoxide dismutase, dithiothreitol (DTT), 5,5'-dithio- 
bis(2-nitrobenzoic acid)  (DTNB), N-ethyhnaleimide (NEM), and 
all compounds used to make both control and Ic~a. extracelhdar 
and intracellular solutions were obtained from Sigma. High pu- 
rity ryanodine, 8-bromo-cyclic GMP, staurosporine,  H-7, and tet- 
rodotoxin  (TTX)  were  obtained  from  Calbiochem  Corp.  (La 
Jolla, CA). SIN-1  was obtained from Alexis Chemical Corp.  (San 
Diego, CA). 
Conventions and Definitions 
For ease  of presentation  the following conventions and  defini- 
tions have been used:  (a)  Unless otherwise indicated, "Ic,,,L" will 
refer to the peak inward basal ICaX. recorded at 0  inV. At 0  mV 
Ic,.L is an  inward current;  accordingly, data points in all figures 
have been plotted on a  negative axis. In all appropriate  figures 
the numbers by any given data point correspond to the indicated 
current recordings shown in the inset, while the solid lines above 
the data points correspond to the period of indicated compound 
application; (b) "indirect" will refer to modulatory effects on Ic,,,t. 
due to the involvement or activation of intracellular second mes- 
senger systems  (e.g., guanylate cyclase and cGMP); and  (c)  "di- 
rect" will refer to modulatory effects on Ica,L due to redox, S-nitro- 
sylation, and/or oxidation reactions of sarcolemmal thiol groups 
which are accessible to the extracellular environment  (Stamler, 
1994,  1995). 
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RESULTS 
Indirect Inhibitory Effects of Nitric Oxide (NO') on Ica,1~ 
SIN-1 has been widely used in cardiac electrophysiolog- 
ical  studies  as  a  specific  "NO-donor"  compound.  Dur- 
ing its spontaneous  breakdown  sequence  SIN-1  gener- 
ates  both  NO.  and  O~  (superoxide)  free  radicals, 
which  can  then  react  at  nearly  diffusion-limited  rates 
(k ~  3.7  X  10V/M/s)  to  produce  peroxynitrite:  SIN-1 
--+ O~  +  NO.  --+ OONO-  (Feelisch,  1991;  Saran  et al., 
1990;  Stamler  et  al.,  1992b;  Feelisch  and  Stamler, 
1996).  The  effects  of 1  mM  SIN-1  on  ferret  right ven- 
tricular  IC,.L were  not  straightforward,  in  that  it could 
either  reversibly decrease  (-26  -+  5%;  5/13  myocytes; 
Fig.  1A)  or  increase  IC~,L (+35  --+  8%;  5/13  myocytes; 
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FIGURE  1.  Effects of extracellularly applied 1 mM SIN-I on basal 
Ic~,t.. (A) Representative example of reversible inhibition of I(~,L by 
SIN-1.  (B) Representative example of reversible stimulation of IC~,L 
by SIN-1.  (Inset) Summary of 1 mMSIN-1 effects. In 5/13 myocytes 
SIN-1 inhibited I(~a, by -26 _+ 5%, while in 5/13 myocytes it stimu- 
lated Ic~,i~ by +35  •  8%. Fig. 1B). In three additional myocytes, SIN-1 produced 
biphasic effects on Ica,L. 
We hypothesized that in myocytes in which SIN-1 in- 
hibited  Ic~,L the  cellular  redox  conditions  were  such 
that the effects of NO. were dominant, leading to inhi- 
bition  of ICa,L through  cGMP.  On  the  other  hand,  in 
those  myocytes in  which  SIN-1  stimulated  Ica,l,  we  hy- 
pothesized that S-nitrosylation- and/or  oxidation-medi- 
ated  signals  lead  to  channel  activation.  To  test  for 
cGMP-dependent  mechanisms  we  reevaluated  the  ef- 
fects of 1 mM SIN-1 in the presence of 750-3,000 U/ml 
superoxide  dismutase  (SOD),  so  as  to  minimize  pro- 
duction  of  OONO-.  Under  these  conditions  1  mM 
SIN-1  produced  a  consistent and  reversible inhibition 
of Ica,L of -17  +  4%  (n  =  3  myocytes; Fig. 2A). More- 
over,  extracellular  application  of  10-100  IxM  8-Br- 
cGMP consistently inhibited Ic~,L (Fig. 2B). In five myo- 
cytes where  steady-state effects were obtained,  100  IxM 
8-Br-cGMP inhibited Ic,,L by -30  -+ 9%.  Compared  to 
SIN-1  +  SOD,  the  inhibition produced  by 8-Br-cGMP 
was greater  (Fig. 2B,  inset), possibly due to the fact that 
8-Br-cGMP is relatively phosphodiesterase  resistant. Fi- 
nally, myocytes were  preincubated  for at least ->8 min 
in  100  IxM 8-Br-cGMP  (to allow steady-state inhibition 
of Ic~,L to be obtained) and then exposed to 1 mM SIN-I. 
In  the  continual presence  of 8-Br-cGMP,  SIN-1 was ei- 
ther without  effect  (2/7  myocytes)  or  significantly in- 
creased ICa,L by  +105  +  17%  (5/7  myocytes; Fig. 2C). 
In no instance in the presence of 8-Br-cGMP was a fur- 
ther inhibition of ICa,L by SIN-1 observed. Taken  in ag- 
gregate, these results indicate that:  (a)  NO- can inhibit 
ferret right ventricular Ica,L through an indirect cGMP- 
dependent  pathway,  and  (b)  OONO  may be  capable 
of stimulating ICa,L , either through redox and/or  S-nitro- 
sylation reactions. 
Stimulatory Effects of S-Nitrosothiols (NO + Transfer) on Ic,,,L 
To  test the  hypothesis that the stimulatol  T  effects pro- 
duced by SIN-1 in some myocytes may have been due to 
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FI(;URE 2.  (A)  SIN-1 and SOD.  In the presence of superoxide 
dismutase (SOD; which would promote NO. production and pre- 
vent OONO- formation) SIN-1 consistently inhibited Ic,,i.. Repre- 
sentative result from one myocyte exposed to 1 mM SIN-1 +  1500 
U/ml SOD. Ica,L  was reversibly inhibited by ~18%. (B) Representa- 
tive results from one myocyte on extracellular application of 100 
IxM 8-Br-cGMP. 100 IxM 8-Br-cGMP consistently inhibited I(:~a  .. (In- 
set) Summary and comparison of mean inhibitory effects produced 
by 100 txM 8-Br-cGMP (-30 +- 9% inhibition, n = 5 myocytes) and 
1  mM SIN-1 +  SOD (-17 -+ 4% inhibition, n =  3 myocytes). (6) 
Representative results from one myocyte on the effects  of 1 mM 
SIN-1 after inhibitory steady-state effects of 100 p,M 8-Br-cGMP had 
been obtained. (Inset) Summary of effects of 1 mM SIN-1 in the 
presence of 100 txM 8-Br-cGMP. In the presence of 8-Br-cGMP, in 
2/7 myocytes SIN-1 had no effect on I(:,,L,  while in 5/7 myocytes it 
significantly stimulated I(~,,l. by +105  +  17%.  In the presence of 
8-Br-cGMP in no instance was an inhibition of I(:,.  L by SIN-1 ob- 
served. 
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two  naturally  occurring  S-nitrosothiols  that  support 
NO + transfer chemistry (i.e., S-nitrosylation), S-nitroso- 
glutathione  (GSNO)  and  S-nitrosocysteine  (CySNO). 
Extracellular application of  1  mM  GSNO  consistently 
produced  a  significant increase  in  ICa,L (+61  -+  11%, 
n  =  7 myocytes) which was slowly reversible upon wash- 
out  (Fig.  3  A),  The  stimulation  of lc,,L  could  be  re- 
peated upon  a second application of GSNO, and in no 
instance was  inhibition of IC~,L observed.  Thus,  the  ef- 
fects of GSNO  (NO +)  on IC,,L were diametrically oppo- 
site  to  those  produced  by NO'.  Since when  perfusing 
GSNO  1 mM Na + was also reintroduced into the extra- 
cellular solution (see METHODS)  control measurements 
were conducted in the presence of 50 ~M tetrodotoxin 
(TTX).  In  the  presence  of  TTX,  1  mM  GSNO  in- 
creased Ic~,e by +63 _+  18%  (n =  6 myocytes; Fig. 3 B), a 
mean value of stimulation very similar to that observed 
under  control  conditions.  The  results  obtained  with 
TTX  indicated  that  the  1  mM  Na §  reintroduced  into 
the  extracellular recording  solution  was  not  a  signifi- 
cant factor in mediating the effects of GSNO upon IC~,L. 
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FIGURE 3.  Effects of extracellular RSNOs  (S-nitrosylation) and RSH (reduction) on  I(ka, L.  (A) 1 mM GSNO consistently stimulated I(~,l  .. 
Representative result from one myocyte. The effects were both reversible and repeatable. (B) Representative result from one myocyte on 
the effects of 1 mM GSNO on I<:,.t.  in the presence of 50 IxM TTX.  (Inset) Summary and comparison of stimulatory GSNO effects under 
control conditions and in the presence of 50 txM T1N. Mean stimulation values: GSNO control, +61 -+ 11% (n = 7 myocytes); GSNO con- 
trol +  TFX, +63 _+  18%  (n =  6 myocytes). (C)  1 mM reduced glutahtione (GSH) consistently inhibited 1c~,.  L. Results in this myocyte are 
representative of 6 similar experiments. (Inset) Summary and comparison of GSNO and GSH results. Mean values of stimulation/inhibi- 
tion as follows: 1 mM GSNO, +61  --+ 11% (n =  ? myocTtes); 1 mM GSH, -31  + 7% (n =  6 myocytes). (D) 1 mM S-nitrocysteine (CySNO) 
consistently stimulated I(:,.i..  Representative result fi-om one myocyte, where CySNO initially  transiently stimulated I(:~,l.  by nearly 150% (see 
text for details). 
28]  CAMPBELL ET AL. Finally, in a separate  series of control experiments  the 
effects  of  extracellular  reduced  glutathione  (GSH,  1 
raM)  were  determined.  In  contrast  to  GSNO,  1  mM 
GSH consistently inhibited It,,1. (-31  +  7%; n =  6 myo- 
cytes;  Fig.  3  C).  Therefore,  the  stimulator,/  effects  of 
GSNO were specifically related to the NO group. 
Like  GSNO,  1  mM  S-nitrosocysteine  (CySNO)  also 
consistently  and  reversibly  increased  lc~,,l, (Fig.  3  D). 
However,  by comparison  to GSNO,  the initial stimula- 
tory effect  was  more  transient  (n =  4  myocytes).  This 
was  probably  related  to  the  short  half-life  of CySNO 
(Feelisch  and  Stamler,  1996).  Because  GSNO  is  both 
stable and cell impermeable, we used it to probe for po- 
tential extracellular redox sites  (see below). 
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0.3t/(1  +  exp[22  -  V)/8].  (Q  Kinetics of I~:.,i, macroscopic inactivation at 0  inV. Representative double exponential iit.s with indicated 
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parameters as follows: control, % =  17.5 •  2.1 ms, %  =  79.3 _+ 2.4 ms, A~/(A  1 +  A,,)  =  0.636 +_ 0.044; 1 mM GSNO, %  =  13.9 •  1.3 ms, % = 
89.8 •  4.5 ms, AI/(A I +  A~)  =  0,694 •  0.033. Statistical significance levels: %  0.01  <  P  <  0.02; %, 0.02 <  P <  0.05; At/(Ai  +  A,_,), 0.02 < 
P <  0.05.  (D)  Mean kinetics of recovery from inactivation at HP =  -70  mV (protocol shown in schematic inset). Mean recovm  T data for 
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%,(. =  75 ms and n =  1.55. 
282  Redox Modulation of b~'ret Ventricular lc..r Effects  of GSNO  on  Ic,,L  macroscopic  gating  characteris- 
tics.  GSNO  increased  the  amplitude  of the  peak  cur- 
rent-voltage (I-V) relationship  (+ 61  -+ 11% increase at 
0  mV) without significantly affecting either the appar- 
ent reversal potential or the isochronal  (500 ms) I-V re- 
lationship  (Fig.  4A).  The VI/2 of the  mean  estimated 
steady-state  activation  curve  (Fig.  4  B)  was  slightly 
shifted by -6.5  mV in the hyperpolarized direction by 
GSNO, without any significant alteration in other esti- 
mated  activation  parameters  (see  Fig.  4  B,  legend). 
Similarly, GSNO had no significant effect on either the 
mean "U-shaped" steady-state inactivation  relationship 
(Fig.  4B)  or the  kinetics of recovery from inactivation 
mesured at HP =  -70 mV (Fig. 4 D; see legend). While 
the  parameters  of  Ic~,l  macroscopic  inactivation  in 
GSNO were calculated to be significantly different from 
control conditions  (Fig. 4  C; mean values to double ex- 
ponential fits given in Fig. 4 C legend), the overall alter- 
ations in inactivation kinetics were nonetheless minor. 
It should be noted that a -6.5 mV shift in the estimated 
activation  curves would  increase  peak Ic~,L at 0  mV by 
only 9%.  Hence,  additional  factors  (i.e.,  increases  in 
Npo and/or i) must also be operative to account for the 
stimulatory effects of GSNO observed. 
Is the Stimulatory Effect of GSNO on Ica,  i~ due to Indirect or 
Direct Mechanisms ? Tests of Potential Indirect Mechanisms 
Inhibition of SR Ca  2+ release. GSNO could potentially stim- 
ulate  Ic~,,  L  through  reduction  or  inhibition  of  Ca  2+- 
induced Ca  9+ release from the sarcoplasmic reticulum, 
which in turn would reduce a significant component of 
CaZ+-induced inactivation  (Mitchell  et al.,  1984;  Balke 
and Wier,  1991;  Imredy and Yue,  1994;  Campbell and 
Strauss,  1995; Y.  Qu  and  D.L.  Campbell,  unpublished 
observations). To test this SR Ca  2+ hypothesis, myocytes 
were first preincubated  for  >60  min in  20  txM ryano- 
dine to achieve complete steady-state block of the RY  z- 
type SR Ca  2+ release channel (Meissner,  1995). In addi- 
tion,  20  IxM ryanodine was also included  in  the  patch 
pipette  solution.  However, after pretreatment with  ry- 
anodine  1 mM GSNO was still able to consistently and 
significantly increase Ic~,,L by +65  +  26%  (n =  3  myo- 
cytse; Fig.  5), a value comparable to that observed un- 
der control conditions  (see Fig.  8). These results indi- 
cate that the effects GSNO are not obligatorily depen- 
dent upon modulation of SR Ca  `)+ release. 
Kinaseactivation.  GSNO  could  indirectly  stimulate 
Ica,L through  activation of a  protein  kinase  or kinases 
(e.g., cAMP-dependent PKA, PKC, or some other pres- 
ently  unknown  kinase  "PKX"  [Hartzell  et  al.,  1995]). 
To  test  this  indirect  kinase  hypothesis  two  different 
nonspecific  kinase  inhibition  protocols were  applied. 
Both protocols involved simultaneous extracellular ap- 
plication  of two kinase  inhibitor  compounds,  200  nM 
staurosporine and 50 ~M H-7. At these high concentra- 
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FIGURE 5.  RSNO  and SR regulation.  Reduction  or inhibition  of 
SR Ca  `'+ release. Representative results from one myocyte after SR 
Ca  2+ release had been inhibited  with 20 I~M ryanodine  (see text 
for details). 1 mM GSNO increased IC,,L to an extent similar to that 
observed under control conditions  (see Fig. 8). 
tions, the combination of staurosporine  +  H-7 should 
have  inhibited  all  presently known  kinases  in  cardiac 
myocytes (Hartzell, 1988; McDonald et al., 1994; Camp- 
bell and Strauss, 1995). 
In  the  first protocol  a  series of control  ICa,L record- 
ings were obtained using the standard control patch pi- 
pette solution  (5 mM ATP,  5 mM creatine phosphate, 
and  200  IxM  GTP  present;  see  METHODS).  Staurospo- 
rine  +  H-7 were then  extracellularly applied for 8-20 
min, whereupon 1 mM GSNO was applied. Initial appli- 
cation of staurosporine  +  H-7 consistently produced a 
significant inhibition of Ica,L of --69 _+ 6%  (Fig. 6 A and 
inset). These results indicate that, under the recording 
conditions  employed,  a  significant  component  of the 
basal Ica,L in  ferret right ventricular myocytes is main- 
tained  by the  activity of a  (presently unidentified)  ki- 
nase or kinases  (Tsien et al., 1986;  Hartzell, 1988; Ono 
and  Fozzard,  1992,  Herzig et al.,  1993;  Ono  and  Foz- 
zard,  1993; McDonald et al.,  1994; Hartzell et al., 1995; 
Campbell  and  Strauss,  1995).  However,  1  mM  GSNO 
was still able to increase the IC~,L  remaining after signifi- 
cant nonspecific kinase inhibition  (Fig. 6, B and  C). In 
a total of 6 myocytes in which this first protocol was ap- 
plied,  1 mM GSNO increased the basal Ic~,i  ' remaining 
after  8-20  min  exposure  to  staurosporine  +  H-7  by 
+54 -4- 10%  (see Fig. 8). 
To further test the indirect kinase hypothesis, a more 
stringent second kinase inhibition protocol was also ap- 
plied.  Myocytes were first preincubated for >1  h  (and 
typically >2-3  h)  in staurosporine  +  H-7, plus stauro- 
sporine  +  H-7 were continually perfused under all re- 
cording conditions. In an attempt to eliminate or mini- 
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FIGURV 6.  RSNO and kinase regulation. (A, B, and (7) Representative  results of first kinase inhibition protocol (see text for details).  (A) 
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cytes). (B and C). After "steady-state" staurosporine + H-7 inhibition had been achieved,  1 mM GSNO increased Ic,.l. to an extent similar to 
that observed under control conditions (see Fig. 8). Results from two different myocytes. (D) Representative  results of second kinase inhi- 
bition protocol (patch pipette ATP replaced with ATP-3,S; see text for details) from one myocyte. 1 mM GSNO reversibly increased residual 
basal I(:~d  to an extent similar to that observed under control conditions (see Fig. 8). Similar results observed in a total of 9 myocytes. 
mize all intracellular phosphorylation reactions, the patch 
pipette  solution was modified by including 50 ~M H-7 
and replacing control 5 mM ATP with 5 mM ATP-~-S (a 
nonhydrolyzable  ATP-analogue)  and  completely  re- 
moving creatine phosphate and GTP. Finally, myocytes 
were perfused for at least  15-20 rain before GSNO ap- 
plication.  Under these conditions the peak "basal" ICa,L 
was quite  small  (typically under  100 pA).  Nonetheless, 
1 mM GSNO still reversibly increased the residual basal 
Ic~,,i~ by +65 _+  16%  (n =  9 myocytes; Fig. 6 D). 
Phosphatase inhibition.  GSNO could potentially stimu- 
late  Ica,h  through  inhibition  of  basally  active  phos- 
phatase  activity  (e.g.,  Ono  and  Fozzard,  1993;  Imredy 
and Yue,  1994). To nonspecifically inhibit or attenuate 
phosphatase  activity  120 mM KC1 in  the  patch  pipette 
was replaced with  120 mM CsF  (Shenolikar and Nairn, 
1991;  Neumann  et  al.,  1993;  Imredy and Yue,  1994). 
Under  these  conditions,  in  many  myocytes  (n  =  8) 
peak I(:~.  L continued to progressively grow in amplitude 
even  after  20  min  of  CsF  peffusion.  Such  behavior 
would  be  consistent  with  inhibition  of  (presently  un- 
identified)  basally active phosphatases, resulting in "un- 
opposed"  basal  kinase  activity.  Due  to  this  complica- 
tion,  recordings were  made from relatively small  myo- 
cytes, so as to acheive both adequate internal perfusion 
of CsF  and  steady-state  effects  within  20  rain.  Under 
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B). Hence, the stimulator/effects of GSNO on ICa,L are 
not obligatorily dependent  upon alterations in intracel- 
lular cGMP levels. 
The mean results from all of the tests for possible in- 
direct  mechanisms  (SR  Ca  2+  release,  kinases,  phos- 
phatases, cGMP)  are summarized in Fig. 8.  The stimu- 
latory effects of GSNO  on  Ica,L under  all of the  condi- 
tions  tested were very similar to those  obtained under 
control conditions. 
Possible Direct Mechanisms: Tests for an Extracellular 
"Redox Switch" 
The  opposing  effects  on  IC~,L of reduced  glutathione 
(reducing agent) versus GSNO and OONO-  (S-nitrosy- 
lating and  oxidizing agents)  raised the  possibility that 
the modulatory effects of these compounds  were medi- 
ated through  direct redox and/or  S-nitrosylation reac- 
tions at an  extracellular "redox switch(es)" containing 
critical thiol groups  (e.g., Lipton et al.,  1993;  Stamler, 
1994;  Gozlan  and  Ben-Ari,  1995;  Lipton  et al.,  1996). 
To test this hypothesis we examined the effects of extra- 
cellular application of three thiol-specific reagents:  (a) 
DTT  (dithiothreitol),  a  thiol-specific reducing  agent; 
(b)  DTNB  (5,5'-dithio-bis[2-nitrohenzoic  acid]),  a 
thiol-specific oxidizing agent; and (c) NEM  (N-ethylma- 
leimide), an irreversible thiol alkylating agent. 
Effects of DTT and DTNB.  Fig. 9, A  and  B show repre- 
sentative  results obtained from  two  different myocytes 
on  the  effects  on  Ic~,L of  2  mM  DTT  and  200  txM 
DTNB.  Extracellular  application  of DTT  produced  a 
significant inhibition of I<,,L.  Furthermore,  the  inhibi- 
FIGURE 7.  (A)  GSNO and phosphatase inhibition. Representa- 
tive results from one myoctye after intracellular perfusion of 120 
mM CsF for 20 rain (see text for details). 1 mM GSNO reversibly 
increased Ic,.i (see Fig. 8). (B) GSNO and alterations in cGMP lev- 
els. Representative results from one myocyte which had been pre- 
incubated in 100 IxM 8-Br-cGMP for ~10 min. 1 mM GSNO revers- 
ibly increased I<,,t  ' (see Fig. 8). 
such  conditions,  1  mM  GSNO  was  still able  to  signifi- 
cantly and reversibly increase basal Ic~,l by +48  -+  7% 
(n =  3 myocytes; Fig. 7 A). 
Alterations in intracellular  cGMP levels.  GSNO  could po- 
tentially stimulate Ice.t.  by lowering intracellular cGMP 
levels.  To  test  this  possibility, myocytes were  preincu- 
bated for  ->10 minutes in  100  I~M 8-Br-cGMP to allow 
steady-state  inhibitory  effects  to  be  obtained.  Since 
8-Br-cGMP is relatively phosphodiesterase resistant, this 
manueuver  should  have  effectively  "clamped"  (or  at 
least minimized any changes in)  the intracellular level 
of cGMP.  In  the  continual  presence  of 8-Br-cGMP,  1 
mM GSNO was still able to significantly and reversibil- 
ity stimulate Ice,t. by +73  +  31%  (n =  5 myocytes; Fig. 7 
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FIGURE 8.  Mechanism of GSNO stimulation: summary. The stim- 
ulatory effects of GSNO on It,,.  L under all conditions tested were 
very similar to those produced under control conditions. Mean % 
stimnlation values as follows: GSNO control, +61  -+ 11% (n =  7); 
GSNO control +  TTX,  +63  +  18%  (n =  6); 20 p.M ryanodine, 
+65 +  26%  (n =  3); 120 mM CsF, +48 +- 7% (n =  3); staurospo- 
fine  +  H-7: first kinase inhibition protocol (ATP),  +54  _+  10% 
(n = 6), second kinase inhibition protocol (ATP-~/-S), +65 -  16% 
(n = 9); and 8-Br-cGMP, +73 _+ 31% (n = 5). 
285  CAMPBELI.  ET  AL. tory effects of DTT could be reversed by subsequent ap- 
plication of DTNB. In addition, DTNB also produced a 
significant stimulation  of Ic~,L (Fig. 9B).  Similar results 
(1-5 mM DTT, inhibition; 200 txM DTNB, stimulation) 
were obtained in 5  myocytes. DTNB is relatively mem- 
brane  impermeant  (Aizenmann  et al.,  1989; Lei et al., 
1992;  Tang  and  Aizenmann,  1993).  Therefore,  its  ef- 
fects on Ic~,,  L may be attributed  to redox reactions with 
sarcolemmal thiol groups. These effects therefore indi- 
cate  that  alteration  of the  redox state  of sarcolemmal 
thiol  groups can significantly modulate  Ic~.L  ' with  thiol 
reduction  producing  down  regulation  and  oxidation 
up regulation of Ic,,L. 
Effects of DTT on GSNO response.  GSNO  is  cell  imper- 
meant.  Thus its  effects on  Ica,L more  than  likely occur 
through action at the cell surface. To determine  if the 
effects of GSNO could be reversed by reduction  of ex- 
tracellular  thiol  groups,  the  effects  of DTT  were  ex- 
plored.  Fig.  9,  C and  D  show that GSNO-mediated  in- 
creases  in Ic~,~" could be partially reversed  in a  concen- 
tration-dependent manner by simultaneous application 
of 1-5 mM DTT  (n =  4  myocytes). While  these  results 
do not demonstrate  that DTT and  GSNO are exerting 
their opposing effects through interactions at the same 
extracellular redox site(s),  they do establish  that GSNO- 
mediated stimulation of IC,,L is reversible and mediated 
by  interactions  with  extracellular  sarcolemmal  thiol 
groups.  Ahnost  certainly,  GSNO  catalyzes  S-nitrosyla- 
tion-mediated  disulfide  formation  (Arnelle  and  Stam- 
ler,  1995). 
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286  Redox Modulation of l%rret Ventricular Ic,,.1 Effects ofNEM.  5;ethylmaleimide  has  been  demon- 
strated to covalendy modify protein thiol groups, thereby 
preventing subsequent S-nitrosylation reactions (Stam- 
ler  et  al.  1992a;  Bolotina  et  al.,  1994;  Lipton  et  al., 
1996). If the direct extracellular redox switch hypothe- 
sis is correct, then it should have been possible to elimi- 
nate or greatly attenuate the effects of GSNO by prior 
extracellular application of 1 mM NEM. The effects of 
NEM alone on Ic~,L  were complicated, in that it initially 
significantly stimulated  and  then  subsequently  inhib- 
ited Ic~.L (Fig. 10 A; n =  5 myocytes). The early stimula- 
tion is consistent with modification of extracellular thi- 
ols, whereas later inhibition  may derive from nonspe- 
cific alkylation of other (intracellular)  thiol containing 
proteins (e.g., kinases or phosphatases; Figs. 6, 7, and 8). 
Due  to these  complicated biphasic  effects, attempts 
were made to obtain steady-state effects by first incubat- 
ing myocytes for 20-30 min in 0.1-1  mM NEM.  How- 
ever,  these  attempts  were  thwarted  by  the  fact  that 
NEM exposure times of >20 min resulted in significant 
damage to or killing of all the exposed myocytes. As a 
result,  the  following alternative protocol was  applied: 
(a) in any given myocyte, 1 mM GSNO was first applied 
for ~3-5 min to obtain an estimate of control stinaula- 
tion; (b)  1 mM NEM was then applied for 10-15 rain to 
obtain  approximate steady-state effects; and  (c)  1 mM 
GSNO was then reapplied. Fig. 10, B and Cshow repre- 
sentative results obtained from two different myocytes 
where this GSNO-NEM-GSNO protocol was applied (a) 
GSNO  initially  stimulated  IC~,L; (b)  1  mM  NEM  ulti- 
mately reversed the GSNO-mediated stimulation  back 
to or below initial control levels; and (c) the second ap- 
plication of GSNO either failed to produce any effect 
(Fig. 10 B) or was significantly attenuated compared to 
the  initial  control stimulation  (Fig.  10  C;  compare  to 
Figs. 3 A and 6 B). Similar results were observed in a 
total of 7 myocytes. These results strongly suggest that 
the stimulatory effects of GSNO on Ica,L are being me- 
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FIGURE 10.  The extracelhflar redox site: NEM/GSNO. Effects of 
NEM, an irreversible thiol alkylating agent. (A) Extracellular 1 mM 
NEM consistently produced biphasic effects upon Ic,.L i.e., an ini- 
tial stimulation followed by a  maintained inhibition. Representa- 
tive results from one myocyte. (B and (3. NEM abolishes or inhib- 
its GSNO-mediated stimulation. Results from two different myo- 
cytes using the GSNO-NEM-GSNO protocol described in the text. 
In both myocytes illustrated, an approximate 10-15-rain exposure 
to 1 mM NEM was either able to completely abolish (B) or signifi- 
cantly attenuate (C)  the stimulatory effects of a second application 
of 1 mM GSNO compared to the stimulation produced under ini- 
tial control conditions (compare to Figs. 3 A and 6 B). diated through interactions with an extracellular redox 
switch, i.e., through direct S-nitrosylation and/or  disul- 
fide reactions. 
DISCUSSION 
Our results indicate that there are at least two opposing 
signal transduction pathways by which NO-related activ- 
ity  (NO-, OONO-,  RSNOs)  can  modulate  ferret right 
ventricular  basal  Ic~.L (Fig.  11).  Increases  in cGMP  in- 
hibit  ICa,L  , whereas  S-nitrosylation and/or  oxidation  of 
the channel subunit complex stimulate  Ic~,L. Direct re- 
dox  modulation  is  not  dependent  upon  changes  in 
[ Caz+ ] i, kinase activation, phosphatase inhibition, or al- 
terations in cGMP levels  (although these indirect intra- 
cellular processes may be capable of modulating or al- 
tering  direct  effects;  see  below).  Rather,  reduction  of 
allosteric-site  thiols  leads  to direct down  regulation  of 
Ic~,.L while thiol oxidation leads to direct up regulation. 
NEM 
GSH,  DTT  -  4,lc,~$5[<:  :/,  +  [.  DTNB  -  ?lca.L 
+ 
...........  OONO"  ~----  S-rlitrosothiols  (RSNO;  NO +) 
SOD  ~  : 
+  +  Mechanis,*n: 
r ecouiatory site 
.  +) s  nitrosylatior, of 
inhibition  \~..  \\,?  [Q'N~  //  (RS-No);Single  reg ......  ar~d/orY thiols 
Mechanism:  ~  ~  ~  ii) Disulfide formation 
cGMP-dependent  ~  between  vicnal  thiols 
eNOS?  {RS-SR')  9 
External  NOS? 
Fmu~E  11.  Hypothesized model for direct and indirect modula- 
tion of ventricular ICa,L by NO-related activity and S-nitrosothiols 
(NO+).  +, denotes stimulation,  -, inhibition, solid arrows desig- 
nate established  pathways, dashed arrows  potential physiological 
pathways.  NOS, nitric  oxide  synthase;  Ox-Red, NAD(P)H  oxi- 
doreductases;  and  F,  CSOD,  extracellular  superoxide  dismutase 
(Stamler,  1996).  For illustrative  purposes the  redox site  (repre- 
sented schematically by the extracelllular  S-S domain) is shown as- 
sociated with the L-channel subunit complex or another closely as- 
sociated  molcule(s). However, neither the exact location nor the 
total number of direct modulatory redox sites is presently  known. 
This  redox site(s)  is accessible  to extracellular  reducing  (GSH, 
DTT)  and  oxidizing  (OONO  ,  DTNB)  agents,  with  reduction 
causing direct inhibition and oxidation direct stimulation  of Ic~,.L. 
The effects of this site (s) can be abolished by alkylation of critical 
thiols within it by NEM. Within this framework, NO-related activity 
can inhibit Ic~,.  L through an indirect intracellular mechanism in- 
volving activation  of galanylate cyclase, or stimulate  I<,.L  via oxida- 
tinn of the redox site(s).  RSNOs promote disulfide  formation by 
S-nitrosylation  (Arnelle  and Stamler,  1995). Therefore, dual site 
regulation  by S-nitrosylation  (single  thiols)  or oxidation  (vicinal 
thiols)  is  possible.  NOS  activity generates  NO,  OONO-,  and 
RSNO; thus,  both cellular redox state  and location  (i.e., cellular 
source) of NO synthases or NO-donors could be important t~actors 
in  determining  the response of cardiac myocyte  L-type calcium 
channels to N-oxides. 
The actions of endogenous NO and RSNOs will therefore 
be critically dependent upon both the site of synthesis and 
the  local redox milieux  (see below). To the  best of our 
knowledge, this is the first demonstration of redox modu- 
lation  of cardiac  L-type calcium  channels,  and  that  NO 
and RSNOs can exert functionally opposite effects upon 
L-type (or, for that matter, any) channel function. 
The exact location of this redox site(s)  is at present 
undetermined.  One  obvious candidate  location  is  the 
L-channel subunit complex, either the pore forming e~ 
subunit,  an  associated  auxiliary  channel  subunit,  or a 
presently unrecognized auxiliary subunit  (e.g.,  Isom et 
al.,  1994;  Hofmann  et  al.,  1994;  Mori,  1994;  Chiamvi- 
monvat et al.,  1995; Campbell and Strauss,  1995; Stea et 
al.,  1995).  While  the  ferret  ventricular  c~ l  subunit  has 
yet to be  cloned,  the  sequences  of other eqc subunits 
indicate ~10-15  cysteine residues located at numerous 
putative extracetlular  sites  (e.g., Stea et al.,  1995),  rais- 
ing the  distinct  possibility of multiple  redox sites  (see 
below). Regarding auxiliary subunits,  the present model 
of the  calcium  channel  %-~  subunit  proposes  a  disul- 
fide group connecting the two subunits  (|ay et al.,  1991). 
Redox alterations  at such a  site could also be possible, 
since  it  has  been  demonstrated  that  coexpression  of 
various  auxiliary  subunits  can  alter  the  amplitude  of 
heterologously  expressed  L-channel  cq  subunits  (Wei 
et  al.,  1991;  Wellig  et  al.,  1993;  P6rez-Garcfa  et  al., 
1995).  Alternatively,  the  redox  site(s)  may be  located 
on  another  adjacent  membrane-bound  molecule(s) 
which  can  directly  interact  with  the  L-channel  com- 
plex. For example, G-proteins could potentially directly 
interact with  the  L-channel  subunit  complex upon  re- 
dox activation/inactivation  (Lander et at.,  1993; Brown, 
1993; Clapham,  1994).  Furthermore,  the  possibility of 
multiple  redox sites  is  not excluded  (see  below).  The 
biphasic effects of NEM on I(:~,L  could be interpreted  as 
evidence for dual-site allosteric regulation. 
Comparison to Previous Results 
Cardiac myocytes.  Our data indicate  that ferret ventricu- 
lar basal  I<,,l is  directly dependent  upon  sarcolemmal 
thiol redox state, an unrecognized factor in all previous 
myocyte studies.  Cellular  redox state  may therefore  be 
an  important  unrecognized factor in  determining  the 
effects  of many  indirect,  second  messenger-mediated 
neuromodulatot y  compounds  on  cardiac  myocytes, 
and may account, at least in part,  for many of the con- 
tradicto W results reported in the cardiac neuromodula- 
to  W  literature  (Hartzell,  1988;  McDonald  et  al.,  1994; 
Campbell and Strauss,  1995). 
The effects of N-oxides on Ic~,,  L in isolated cardiac myo- 
cytes  have  been  conducted  almost  exclusively  under 
conditions of previous  13-adrenergic stimulation  or M:,- 
muscarinic  inhibition,  and  have  focused  exclusively 
upon the possible indirect effects of NO'. Since our mea- 
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difficult to directly compare them with  previous stud- 
ies. For example, SIN-I indirectly inhibits the [3-adren- 
ergically stimulated  Ica.e of bullfrog ventricular  (Mery 
et al.,  1993), rabbit SA nodal  (Han et al.,  1994,  1995), 
and guinea pig ventricular myocytes (Wahler and Doll- 
inger,  1995).  However,  SIN-1  has  been  reported  to 
stimulate Ica,L at least under certain experimental con- 
ditions.  In frog ventricular myocytes 0.1-10 nM SIN-1 
was reported to have no significant effect on basal Ica,L 
but did increase (by 40%) ICa,L  stimulated by a nonmax- 
imal concentration  (0.3 b~m) of forskolin  (Mery et al., 
1993).  In guinea pig ventricular myocytes 10-100  IxM 
SIN-1  was  reported  to  increase  basal  IC~,L by 8-24%, 
while  in  the  presence of 10  nM  isoproterenol  the  ef- 
fects of 10/,M SIN-1  were complicated in that it could 
either  stimulate  or  inhibit  Ic~,L depending  upon  the 
magnitude  of  the  isoproterenol-induced  stimulation 
(Wahler and Dollinger, 1995). None of these previous 
studies considered direct effects, and most did not ap- 
preciate  that  SIN-1  produces  mainly  OONO-  (not 
NO.);  nonetheless,  they emphasize  that the effects of 
SIN-1 are likely to be redox state dependent, and raise 
the  possibility  that  NO-mediated  effects on  Ic~,t" may 
also  be  modulated  or  altered  by  second  messenger- 
mediated and/or phosphorylation reactions. 
Our finding that NO-related activity can inhibit Ica,L 
through an indirect cGMP-dependent mechanism is in 
agreement with numerous previous reports.  However, 
the effects of RSNOs or cellular redox state on Ic~.x. (ei- 
ther  basal,  [3-adrenergically stimulated,  or  M2-musca- 
rinic  inhibited)  have  not  been  adequately studied  in 
other isolated myocyte systems. For example, Mohan et 
al.  (1996)  report  both  stimulatory  and  inhibitory ef- 
fects of NO on contractility of feline right ventricular 
papillary  muscles.  The  applicability  of our  results  to 
I(:~,i. in other cardiac myocyte types therefore awaits fu- 
ture determination. Nonetheless, our results clearly in- 
dicate that under basal conditions NO. and RSNOs can 
exert discrete  and  opposite  effects upon  Ica.L. There- 
fore,  the  assumption  that  NO  only exerts  physiologi- 
cally relevant indirect effects on  cardiac  Ic~,i~ through 
activation of guanylate cyclase clearly needs  to be  re- 
vised. 
Other cell types and ion channels.  The  effects  of  extra- 
cellularly accessible  sulfhydryl modification  on  rabbit 
lung smooth  muscle  L-type Ca 2+  channel  cq  subunits 
expressed  alone  appear  to  be  significantly  different 
from those  exerted on  native right ventricular L-type 
channel subunit complexes. Specifically, sulfhydryl re- 
duction  (DTT) had no effect on currents generated by 
%  subunits;  however, sulfllydryl oxidation significantly 
inhibited  currents,  and  this  inhibition  could  then  be 
reversed by DTT (Chiamvimonvat et al.,  1995). These 
differences may arise from either additional redox-sen- 
sitive interactions with auxiliary [3 and/or ae-8 subunits 
in  native  myocytes,  posttranslational  modifications, 
and/or [3/c~2-8 subunit interactions that induce confor- 
mational  changes  in  the  %  subunit  (and  vice versa) 
which  alter redox responses.  While  these  results  indi- 
cate  the  presence  of redox-sensitive  modulatory sites 
on the L-type Ca  2+ channel %  subunit  (Chimvimonvat 
et al., 1995), they also emphasize the difficulties associ- 
ated  with  extrapolating  physiological  function  from 
simplified expression systems in which only individual 
channel subunits are expressed. It is interesting to note 
that another recent study has demonstrated significant 
differential oxygen sensitivity of native L-type calcium 
channels  in  rabbit  smooth  muscle  cells isolated from 
pulmonary  arterial  conduit  and  resistance  vessels 
(Franco-Obreg6n  and  L6pez-Barneo,  1996).  Specifi- 
cally,  hypoxia  inhibited  ICa,L in  proximal  (conduit) 
smooth  muscle  myocytes but stimulated  Ica,L in  distal 
(resistance)  smooth  muscle  myocytes. The  molecular 
mechanisms underlying this differential oxygen sensitivity 
are presently unknown  (e.g., different channel isoforms 
and/or  different  auxiliary  subunits?).  Nonetheless, 
these results demonstrate that vascular smooth muscle 
ICa,L  can  be  selectively modulated  by redox state  and 
raise the distinct possibility of significant regional and/ 
or  tissue  differences  in  redox-sensitive  modulatory 
properties of L-type calcium channels in the cardiovas- 
cular system. 
A  direct,  cyclic-GMP-independent  modulation  by 
"NO" of the charybdotoxin-sensitive Ca  2+ activated K + 
channel  of rabbit aortic smooth  muscle  has  been  de- 
scribed  (Bolotina et al.,  1994).  Similar to our results, 
this  direct  NO-mediated  inhibition  could  also  be 
blocked by NEM,  suggesting  involvement of an  extra- 
cellular thiol-containing redox switch.  It has  been hy- 
pothesized that direct activation of this Kca channel de- 
rives from the ability of protein RSNO to promote dis- 
ulfide formation between vicinal thiols  (Stamler,  1994; 
Arnelle and  Stamler,  1995).  A  similar  mechanism  has 
also been hypothesized for NO-mediated direct regula- 
tion of type I adenylyl cyclase (Duhe et al.,  1994), pro- 
tein  kinase  C  (Gopalakrishna  et  al.,  1993),  and  the 
NMDA receptor (Lipton et al., 1993). 
Redox  modulation  of native  and  cloned  neuronal 
NMDA  receptors  has  been  extensively studied.  DTT 
stimulates, while both DTNB and S-nitrosylation inhibit 
the NMDA receptor (Aizenmann et al.,  1989; Kuryatov 
et al., 1994; Pan et al., 1995). Therefore, under normal 
oxygenated conditions, NMDA receptor-mediated Ca  e+ 
influx into  neurons  would  be  attenuated,  while  ICa,L- 
mediated Ca  `)+ influx into ventricular muscle would be 
enhanced. Recent mutagenesis studies have also identi- 
fied  at  least  three  separate  NMDA  receptor  subunit 
sites  with  different reactivity profiles  to  DTT,  DTNB, 
and  NEM  (K6hr  et  al.,  1994;  Sullivan  et  al.,  1994; 
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cesses involving several pairs of cysteine residues. This 
raises the possibility that redox modulation of ventricu- 
lar Ic~.L may involve several distinct redox sites, possibly 
located on different molecules. This question can,  in 
principle, be addressed in future studies combining cel- 
lular, biophysical, and molecular biological techniques. 
Possible Pharmacological and Physiological Implications 
"NO Donor" compounds.  The identification of a putative 
extracellular redox site can explain the variable effects 
of SIN-1 on Ic~.l. observed in previous studies. Depend- 
ing upon  the  redox conditions of any given myocyte, 
the effects of SIN-1 could vary from inhibition (NO') to 
stimulation  (OONO-/RSNO).  We also studied the ef- 
fects  of  diethylamine-NO  (DEA-NO)  and  spermine- 
NO, which produce NO.  (Feelisch and Stamler, 1996). 
DEA-NO  consistently  stimulated  while  spermine-NO 
consistently inhibited  IC~.L (n  =  5  myocytes each),  ef- 
fects which were  duplicated  by the  carrier molecules 
alone (DEA, spermine, respectively). Thus, it would ap- 
pear that the cardiac L-type calcium channel may have 
a  modulatory  polyamine  site(s),  similar  to  that  de- 
scribed  for  the  NMDA  receptor  (Johnson,  1996).  In 
summary,  the  effects of many NO-donor  compounds 
reported in the cardiac literature need to be carefully 
reevaluated. 
S-nitrosothiols.  The  effects  of  endogenous  RSNOs 
have been almost exclusively attributed to assumed ho- 
molytic (free radical)  cleavage mechanisms:  RSNO  --~ 
RS"  +  NO.. However, the pharmacological and physio- 
logical profiles of numerous biologically relevant RSNOs 
do not correlate with  charge,  lipophilicity, stability in 
solution, or rates of spontaneous NO- release (Stamler, 
1994, 1995). These results suggest that in biological sys- 
tems  the  effects  of RSNOs  will  be  dependent  upon 
site (s) of production and are exerted in significant part 
through heterolytic cleavage reactions: RSNO --+ RS  + 
NO +. We have used RSNOs  (GSNO, CySNO) as exem- 
plary  NO +  transferring  compounds  to  demonstrate 
that S-nitrosylation can  produce direct stimulatory ef- 
fects on cardiac Ic~.~. distinct from inhibitory effects me- 
diated by cGMP. Our results highlight that direct stim- 
ulation of cardiac Ic,~,L is likely to be produced by other 
endogenous nitrosating species. 
Physiological implications.  Both the atria and ventricles 
possess an extensive endocardial endothelium which pro- 
duces NO, possibly on a beat-to-beat basis (Schulz et al., 
1991; Shah and Lewis, 1993; Siney and Lewis, 1993; Dis- 
riol et al.,  1995). It has been recendy reported that in 
feline right ventricular papillary muscle  the  effects of 
both cGMP and various NO-related agents (S-nitroso-N- 
acetyl-penicillamine, SIN-l, sodium nitroprusside) could 
be modulated by the status of the endocardial endothe- 
lium, and that these NO-related agents could produce 
in  a  concentration-dependent  manner  both  positive 
and  negative  inotropic  effects  (Mohan  et  al.,  1996). 
While endocardial endothelium  removal has been re- 
ported not to alter ferret papillary muscle action poten- 
tial  duration  (Shah  et al.,  1992),  and  its  effects have 
been mainly attributed to  (presently unidentified)  dif- 
fusible  substances  which  appear  to  increase  myofila- 
ment Ca  2+  sensitivity  (Wang and  Morgan,  1992; Shah 
and Lewis, 1993), our results nonetheless raise the dis- 
tinct possibility that the effects of the endocardial en- 
dothelium on cardiac function may also be mediated, at 
least in part, through endogenous RSNOs or NO-related 
oxidizing agents acting on Ic~.L. 
Myocardial cells can also be exposed to N-oxides pro- 
duced by intracardiac nerve terminals, smooth muscle, 
coronary  endothelium,  and  various  circulating  cell 
types (Ignarro, 1990; Moncada et al., 1991; Klimaschewski 
et al.,  1992; Dinerman  et al.,  1993; Michel and Smith, 
1993;  Schmidt  and  Walter,  1994;  Tanaka  and  Chiba, 
1995). Some cardiac myocytes also possess an endoge- 
nous  constitutive  NO  synthase  (e.g.,  rabbit  SA-node 
cells:  Han et al.,  1994,  1995; rat ventricular myocytes: 
Balligand et al., 1995; Kanai et al., 1995) and a cytokine 
inducible NOS  (Brady et al.,  1992; Finkel et al.,  1992; 
Balligand et al., 1994; Haywood et al., 1996). The physi- 
ological significance of many of these findings is pres- 
ently unclear. However, our data suggest that the both 
the location (i.e., cellular source) from which N-oxides 
and RSNOs are generated and the local redox environ- 
ment could be important factors in determining myo- 
cyte response to N-oxides. For example, if NO/RSNOs 
are  produced  intracellularly within  cardiac  myocytes, 
the inhibitory effects of cGMP may predominate. Alter- 
natively,  if NO/O~-  are  generated  either  at  the  sar- 
colemmal surface or from other cellular sources  (e.g., 
endothelial cells, neurons, circulating cells) stimulatory 
NO + transfer and/or oxidation reactions are likely to 
dominate. As  a  result,  the  activity of both  membrane 
bound  NAD(P)H  oxidoreductases  (which  generate 
02)  and extracellular superoxide dismutases  (ECSODs; 
Stamler,  1996)  could also be important factors  (sche- 
matically  depicted  in  Fig.  11).  The  possible  roles  of 
these enzyme systems in cardiac NO-related responses 
is presently unknown. 
Finally,  a  redox site  directly modulating  Ica.l  ' could 
also be of immediate relevance under pathological con- 
ditions. Ischemic conditions would produce a more re- 
ducing extracellular environment, which would lead to 
direct inhibition of ICa,L.  Such  an  effect could be car- 
dioprotective by reducing the  energy requirements of 
ischemic myocytes, as well as reducing the harmful el: 
fects of released catecholamines. Our results also raise 
the  interesting  possibility  of  physiologically  relevant 
NO-/O,~ effects during periods of increased cardiac ac- 
tivity  resulting  from  contraction-associated  localized 
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1994)  or reperfusion  injury.  In particular,  the opposite 
effects of NO  and  OONO-  on  Ica,t suggest  that  under 
certain conditions NO  may actually increase contractility 
if synthesized concomitantly  with O~-. However, such ef- 
fects could also become  potentially arrhythmogenic. 
Summary 
We  find  that:  (a)  both  cGMP-dependent  and  redox 
(S-nitrosylation and/or  thiol oxidation) dependent  mecha- 
nisms are involved in modulation  of ferret right ventric- 
ular ICa,L; (b)  NO-related  activity can exert both  inhibi- 
tory and stimulatory effects upon  IC~,L; and  (c)  Ca  2+ ho- 
meostasis in ventricular myocytes is directly and selectively 
regulated by cellular redox state. These findings strongly 
suggest  that  direct  redox  modulation  of sarcolemmal 
L-type calcium channels  is an important  and physiolog- 
ically relevant  mechanism  for  modulation  of mamma- 
lian cardiac function. 
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